These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10755581)

  • 21. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
    Pelz R; Banaschewski T; Becker K
    Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylphenidate-Induced Enuresis: 3 Case Reports.
    Uzun N; Akinci MA; Karatoprak S
    Clin Neuropharmacol; 2021 Jan-Feb 01; 44(1):37-38. PubMed ID: 33252370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosis in a cocaine-dependent patient with ADHD during treatment with methylphenidate.
    Delavenne H; Duarte Garcia F; Lacoste J; Cortese S; Charles-Nicolas A; Ballon N
    Gen Hosp Psychiatry; 2013; 35(4):451.e7-9. PubMed ID: 22739113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
    van der Feltz-Cornelis CM; Aldenkamp AP
    Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart rate variability and methylphenidate in children with ADHD.
    Buchhorn R; Conzelmann A; Willaschek C; Störk D; Taurines R; Renner TJ
    Atten Defic Hyperact Disord; 2012 Jun; 4(2):85-91. PubMed ID: 22328340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
    Niederkirchner K; Slawik L; Wermelskirchen D; Rettig K; Schäuble B
    Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
    Bukstein OG; Kolko DJ
    J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate-induced visual hallucinations.
    Porfirio MC; Giana G; Giovinazzo S; Curatolo P
    Neuropediatrics; 2011 Feb; 42(1):30-1. PubMed ID: 21500140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABCB1 c.2677G>T variation is associated with adverse reactions of OROS-methylphenidate in children and adolescents with ADHD.
    Kim SW; Lee JH; Lee SH; Hong HJ; Lee MG; Yook KH
    J Clin Psychopharmacol; 2013 Aug; 33(4):491-8. PubMed ID: 23771192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD].
    Heger S; Trott GE; Meusers M; Schulz E; Rothenberger A; Rettig K; Medori R; Schreiner A; Remschmidt H;
    Z Kinder Jugendpsychiatr Psychother; 2006 Jul; 34(4):257-65. PubMed ID: 16927568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylphenidate and continuous spike and wave during sleep in a child with attention deficit hyperactivity disorder.
    Sheen VL; Shankar M; Marin-Valencia I; Bridgemohan CH; Torres AR
    Pediatr Neurol; 2013 Jul; 49(1):54-7. PubMed ID: 23827428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine.
    Naguy A; Elsori D; Alamiri B
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):75-76. PubMed ID: 30575406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methylphenidate misuse].
    Bruggisser M; Bodmer M; Liechti ME
    Praxis (Bern 1994); 2012 Feb; 101(5):299-305. PubMed ID: 22377977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children.
    Walitza S; Kämpf K; Oli RG; Warnke A; Gerlach M; Stopper H
    Toxicol Lett; 2010 Mar; 193(1):4-8. PubMed ID: 20026394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.
    Schachar RJ; Tannock R; Cunningham C; Corkum PV
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):754-63. PubMed ID: 9183129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting.
    Silva R; Muniz R; McCague K; Childress A; Brams M; Mao A
    Psychopharmacol Bull; 2008; 41(1):19-33. PubMed ID: 18362868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.